Aadi Bioscience, Inc.AADINASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+42.9%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+42.9%/yr
vs -15.9%/yr prior
Acceleration
+58.9pp
Accelerating
Percentile
P90
Near historical high
vs 3Y Ago
2.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 70.96% |
| Q2 2025 | -326.56% |
| Q1 2025 | 18.53% |
| Q4 2024 | 4.01% |
| Q3 2024 | -63.69% |
| Q2 2024 | 52.44% |
| Q1 2024 | -94.95% |
| Q4 2023 | 19.84% |
| Q3 2023 | 25.21% |
| Q2 2023 | 23.07% |
| Q1 2023 | -99.15% |
| Q4 2022 | -37.25% |
| Q3 2022 | 24.30% |
| Q2 2022 | 43.61% |
| Q1 2022 | -55.83% |
| Q4 2021 | 28.20% |
| Q3 2021 | -445.46% |
| Q2 2021 | -130.15% |
| Q1 2021 | 423.21% |
| Q4 2020 | -7.47% |
| Q3 2020 | -57.20% |
| Q2 2020 | 56.72% |
| Q1 2020 | 3.42% |
| Q4 2019 | 2.92% |
| Q3 2019 | 9.46% |
| Q2 2019 | 42.71% |
| Q1 2019 | -48.41% |
| Q4 2018 | 0.79% |
| Q3 2018 | -147.61% |
| Q2 2018 | 301.04% |
| Q1 2018 | -41.33% |
| Q4 2017 | -14.82% |
| Q3 2017 | 36.48% |
| Q2 2017 | -60.94% |
| Q1 2017 | -3787.10% |
| Q4 2016 | 956.97% |
| Q3 2016 | -100.32% |
| Q2 2016 | 197.02% |
| Q1 2016 | -145232.94% |
| Q4 2015 | 28.34% |